| Product Code: ETC13345003 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Panic Disorder Market was valued at USD 2.1 Billion in 2024 and is expected to reach USD 3.2 Billion by 2031, growing at a compound annual growth rate of 5.60% during the forecast period (2025-2031).
The global panic disorder market is driven by a growing awareness of mental health issues, increased stress levels, and the availability of effective treatments. The market includes medications such as selective serotonin reuptake inhibitors (SSRIs), benzodiazepines, and cognitive-behavioral therapy (CBT) as primary treatment options. The prevalence of panic disorder is rising globally, with factors such as genetic predisposition, environmental stressors, and lifestyle changes contributing to its growth. North America dominates the market due to a high prevalence of panic disorder and a developed healthcare infrastructure. However, the Asia Pacific region is expected to witness significant growth due to increasing healthcare expenditure and rising awareness of mental health issues. Key market players include Pfizer Inc., GlaxoSmithKline plc, and AstraZeneca among others, who are focusing on research and development activities to introduce innovative therapies for panic disorder management.
The Global Panic Disorder Market is witnessing a growing demand for innovative treatment options, driven by an increasing prevalence of anxiety disorders worldwide. Key trends include the rising adoption of virtual therapies and digital mental health solutions, as well as the development of personalized medicine approaches for more targeted interventions. Opportunities in the market lie in the expansion of pharmaceutical pipelines for panic disorder medications, advancements in neuroimaging technologies for better understanding of the disorder, and the integration of AI and machine learning in diagnostic tools. Additionally, the growing awareness and destigmatization of mental health issues are creating a more conducive environment for market growth, with a focus on holistic approaches to treatment and patient-centered care.
The Global Panic Disorder Market faces several challenges, including limited awareness and stigma associated with mental health disorders, underdiagnosis and undertreatment of panic disorder, and a lack of effective and accessible treatment options. Additionally, the high cost of therapy and medication, especially in developing countries, poses a barrier to treatment for many individuals suffering from panic disorder. The variability in symptoms and severity of the disorder also complicates diagnosis and treatment, leading to a need for personalized and tailored approaches. Furthermore, the impact of the COVID-19 pandemic has exacerbated mental health issues globally, including panic disorder, highlighting the urgent need for better resources and support for individuals struggling with this condition. Addressing these challenges will be crucial in improving outcomes and quality of life for individuals with panic disorder.
The Global Panic Disorder Market is primarily driven by increasing awareness about mental health disorders, growing prevalence of panic disorders worldwide, and advancements in diagnostic techniques and treatment options. Rising stress levels, lifestyle changes, and the impact of traumatic events are also contributing factors fueling the market growth. Additionally, the availability of effective pharmacological and non-pharmacological treatment options, along with the focus on early diagnosis and intervention, are propelling the market forward. Moreover, the integration of technology in mental health care, such as telemedicine and digital therapeutics, is further driving the market by improving access to treatment and monitoring for individuals with panic disorders. Overall, a combination of these factors is shaping the growth trajectory of the Global Panic Disorder Market.
Government policies related to the Global Panic Disorder Market typically focus on improving access to mental health services, increasing awareness about panic disorders, and promoting research and development in the field. These policies often include funding for mental health programs, initiatives to reduce stigma around mental illness, and regulations to ensure the safety and efficacy of panic disorder treatments. Governments may also implement measures to improve mental health education and training for healthcare professionals, as well as to support the development of innovative therapies and interventions for panic disorder. Overall, government policies aim to address the growing burden of panic disorders on individuals, families, and healthcare systems by promoting comprehensive and effective strategies for prevention, diagnosis, and treatment.
The Global Panic Disorder Market is expected to witness significant growth in the coming years due to increasing awareness about mental health issues, improved diagnostics, and a growing number of treatment options. The market is likely to be driven by the rising prevalence of panic disorders worldwide, coupled with a shift towards personalized medicine and innovative therapies. Additionally, advancements in telemedicine and digital health solutions are expected to expand access to treatment for individuals suffering from panic disorders. Government initiatives aimed at reducing the stigma associated with mental health conditions and increasing investments in mental health services are also likely to contribute to the market growth. Overall, the Global Panic Disorder Market is anticipated to experience steady expansion as the demand for effective treatments for panic disorders continues to rise.
In the global panic disorder market, North America holds the largest market share due to the high prevalence of anxiety disorders, well-established healthcare infrastructure, and increasing awareness about mental health issues. Europe follows closely behind, driven by growing government initiatives to address mental health concerns and the availability of advanced treatment options. In Asia, there is a rising awareness about panic disorders, leading to increased diagnosis rates and a growing demand for effective treatments. The Middle East and Africa region is experiencing a gradual increase in the prevalence of panic disorders, creating opportunities for market growth. Latin America has a smaller market share compared to other regions, but is witnessing a steady rise in awareness and treatment options for panic disorders, contributing to market expansion.
Global Panic Disorder Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Panic Disorder Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Panic Disorder Market Revenues & Volume, 2021 & 2031F |
3.3 Global Panic Disorder Market - Industry Life Cycle |
3.4 Global Panic Disorder Market - Porter's Five Forces |
3.5 Global Panic Disorder Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Panic Disorder Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Global Panic Disorder Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.8 Global Panic Disorder Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.9 Global Panic Disorder Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Global Panic Disorder Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Panic Disorder Market Trends |
6 Global Panic Disorder Market, 2021 - 2031 |
6.1 Global Panic Disorder Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Panic Disorder Market, Revenues & Volume, By Medication, 2021 - 2031 |
6.1.3 Global Panic Disorder Market, Revenues & Volume, By Psychotherapy, 2021 - 2031 |
6.1.4 Global Panic Disorder Market, Revenues & Volume, By Combination Therapy, 2021 - 2031 |
6.2 Global Panic Disorder Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Panic Disorder Market, Revenues & Volume, By SSRIs & SNRIs, 2021 - 2031 |
6.2.3 Global Panic Disorder Market, Revenues & Volume, By Exposure Therapy, 2021 - 2031 |
6.2.4 Global Panic Disorder Market, Revenues & Volume, By Medication + Therapy, 2021 - 2031 |
6.3 Global Panic Disorder Market, Revenues & Volume, By Therapy Type, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Panic Disorder Market, Revenues & Volume, By Pharmacological, 2021 - 2031 |
6.3.3 Global Panic Disorder Market, Revenues & Volume, By Non-Pharmacological, 2021 - 2031 |
6.3.4 Global Panic Disorder Market, Revenues & Volume, By Multimodal, 2021 - 2031 |
6.4 Global Panic Disorder Market, Revenues & Volume, By End Use, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Panic Disorder Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 Global Panic Disorder Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.4.4 Global Panic Disorder Market, Revenues & Volume, By Mental Health Centers, 2021 - 2031 |
7 North America Panic Disorder Market, Overview & Analysis |
7.1 North America Panic Disorder Market Revenues & Volume, 2021 - 2031 |
7.2 North America Panic Disorder Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Panic Disorder Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Panic Disorder Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Panic Disorder Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Panic Disorder Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.4 North America Panic Disorder Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.5 North America Panic Disorder Market, Revenues & Volume, By Therapy Type, 2021 - 2031 |
7.6 North America Panic Disorder Market, Revenues & Volume, By End Use, 2021 - 2031 |
8 Latin America (LATAM) Panic Disorder Market, Overview & Analysis |
8.1 Latin America (LATAM) Panic Disorder Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Panic Disorder Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Panic Disorder Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Panic Disorder Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Panic Disorder Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Panic Disorder Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Panic Disorder Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
8.4 Latin America (LATAM) Panic Disorder Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
8.5 Latin America (LATAM) Panic Disorder Market, Revenues & Volume, By Therapy Type, 2021 - 2031 |
8.6 Latin America (LATAM) Panic Disorder Market, Revenues & Volume, By End Use, 2021 - 2031 |
9 Asia Panic Disorder Market, Overview & Analysis |
9.1 Asia Panic Disorder Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Panic Disorder Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Panic Disorder Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Panic Disorder Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Panic Disorder Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Panic Disorder Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Panic Disorder Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
9.4 Asia Panic Disorder Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
9.5 Asia Panic Disorder Market, Revenues & Volume, By Therapy Type, 2021 - 2031 |
9.6 Asia Panic Disorder Market, Revenues & Volume, By End Use, 2021 - 2031 |
10 Africa Panic Disorder Market, Overview & Analysis |
10.1 Africa Panic Disorder Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Panic Disorder Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Panic Disorder Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Panic Disorder Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Panic Disorder Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Panic Disorder Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Panic Disorder Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
10.4 Africa Panic Disorder Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
10.5 Africa Panic Disorder Market, Revenues & Volume, By Therapy Type, 2021 - 2031 |
10.6 Africa Panic Disorder Market, Revenues & Volume, By End Use, 2021 - 2031 |
11 Europe Panic Disorder Market, Overview & Analysis |
11.1 Europe Panic Disorder Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Panic Disorder Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Panic Disorder Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Panic Disorder Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Panic Disorder Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Panic Disorder Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Panic Disorder Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
11.4 Europe Panic Disorder Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
11.5 Europe Panic Disorder Market, Revenues & Volume, By Therapy Type, 2021 - 2031 |
11.6 Europe Panic Disorder Market, Revenues & Volume, By End Use, 2021 - 2031 |
12 Middle East Panic Disorder Market, Overview & Analysis |
12.1 Middle East Panic Disorder Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Panic Disorder Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Panic Disorder Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Panic Disorder Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Panic Disorder Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Panic Disorder Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
12.4 Middle East Panic Disorder Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
12.5 Middle East Panic Disorder Market, Revenues & Volume, By Therapy Type, 2021 - 2031 |
12.6 Middle East Panic Disorder Market, Revenues & Volume, By End Use, 2021 - 2031 |
13 Global Panic Disorder Market Key Performance Indicators |
14 Global Panic Disorder Market - Export/Import By Countries Assessment |
15 Global Panic Disorder Market - Opportunity Assessment |
15.1 Global Panic Disorder Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Panic Disorder Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
15.3 Global Panic Disorder Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
15.4 Global Panic Disorder Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
15.5 Global Panic Disorder Market Opportunity Assessment, By End Use, 2021 & 2031F |
16 Global Panic Disorder Market - Competitive Landscape |
16.1 Global Panic Disorder Market Revenue Share, By Companies, 2024 |
16.2 Global Panic Disorder Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |